We work with many providers in the area to make sure that our clients receive the best care for their unique issue. One of the providers in the area of medical IV Ketamine is Southern Ketamine and Wellness. Dr. Harrison Irons was kind enough to sit down with us and explain the process for receiving ketamine treatment. Ketamine infusions are used in the treatment of PTSD, panic disorders, dissociation, dopamine disorders, mood disorders and the management of chronic pain.

Bibliography:

Feder, Adriana, et al. “Efficacy of Intravenous Ketamine for Treatment of Chronic Post-Traumatic Stress Disorder: A Randomized Clinical Trial.” JAMA Psychiatry, vol. 71, no. 6, 2014, pp. 681-688.
Dore, Jeffrey, et al. “Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy.” Journal of Psychoactive Drugs, vol. 51, no. 2, 2019, pp. 189-198.
Andrade, Chittaranjan. “Ketamine for Depression, 1: Clinical Summary of Issues Related to Efficacy, Adverse Effects, and Mechanism of Action.” The Journal of Clinical Psychiatry, vol. 78, no. 4, 2017, pp. 393-402.
Goldberg, Mark E., et al. “Use of Ketamine in Pain Management.” Acta Anaesthesiologica Scandinavica, vol. 54, no. 6, 2010, pp. 672-683.
Jelen, Leszek A., et al. “Ketamine: A Promising Novel Antidepressant.” The International Journal of Neuropsychopharmacology, vol. 24, no. 1, 2021, pp. 77-88.

Further Reading:

Schoevers, Robert A., et al. “Adding Psychotherapy to Antidepressant Medication in Depression and Anxiety Disorders: A Meta-Analysis.” World Psychiatry, vol. 19, no. 1, 2020, pp. 77-93.
Arias, Andrew J., et al. “Pharmacology of Ibogaine and Noribogaine.” The Psychedelic Medicine, Edited by Michael P. Bogenschutz, Humana Press, 2018, pp. 145-181.
Sanacora, Gerard, et al. “Targeting the Glutamatergic System to Develop Novel, Improved Therapeutics for Mood Disorders.” Nature Reviews Drug Discovery, vol. 7, no. 5, 2008, pp. 426-437.
Zorumski, Charles F., et al. “Ketamine: NMDA Receptors and Beyond.” The Journal of Clinical Psychiatry, vol. 77, no. 7, 2016, e848-e852.
Mathew, Sanjay J., and José A. González-Heydrich. “Clinical Efficacy and Mechanisms of Ketamine for Depression and Pain: Insights from Neuroscience.” The American Journal of Psychiatry, vol. 177, no. 1, 2020, pp. 5-7.